Riassunto
L’infertilità rappresenta una possibile complicanza dell’obesità. Nell’uomo, essa favorisce una riduzione del testosterone e alterazioni degli speramatozoi, oltre che la disfunzione erettile. Nella donna, l’infertilità dovuta all’obesità è solitamente di tipo anovulatorio. Anche l’efficacia attuale delle tecniche di fertilizzazione assistita può essere ridotta. La sindrome dell’ovaio policistico, frequentemente associata a obesità, rappresenta la condizione più comune di infertilità anovulatoria.
This is a preview of subscription content, log in via an institution to check access.
Bibliografia
Pasquali R 2006 Androgens and obesity: facts and perspectives. Fertil Steril 85:1319–1340.
Bélanger C, Houldc F-S, Lebelc S, Bironc S, Brochuc G, Tchernof A 2006 Omental and subcutaneous adipose tissue steroid levels in obese men. Steroids 71:674–682.
Isidori AM, Caprio M, Strollo F, et al 1999 Leptin and androgens in male obesity: evidence for leptin contribution toreduced androgen levels. J Clin Endocrinol Metab 84:3673–2680.
Foresta C, Di Mambro A, Pagano C, Garolla A, Vettor R, Ferlin R 2009 Insulin-like factor 3 as a marker of testicular function in obese men. Clin Endocrinol (Oxf) 71:722–726.
Aggerholm AS, Thulstrup AM, Toft G, Ramlau-Hansen CH, Bonde JP 2008 Is overweight a risk factor for reduced semen quality and altered serum sex hormone profile?. Fertil Steril 90:619–626.
Sermondade N, Faure C, Fezeu L, et al 2013 BMI in relation to sperm count: an updated systematic review and collaborative meta-analysis. Hum Reprod Update 19:221–231.
Corona G, Lee DM, Forti G, et al 2010 Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). J Sex Med 7:1362–1380.
Corona G, Rastrelli G, Monami M, et al 2013 Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol 168:829–843.
Pasquali R, Gambineri A, Pagotto U 2006 The impact of obesity on reproduction in women with polycystic ovary syndrome. Br J Obstet Gynecol 113:1148–1159.
Moran LJ, Dodd L, Nisenblat V, Norman RJ 2011 Obesity and reproductive dysfunction in women. Endocrinol Metab Clin North Am 40:895–906.
Fedocksák P, Dale P, Storeng R et al 2004 Impact of overweight on assisted reproduction treatment. Hum Reprod 11:2523–2552.
Bellver J, Busso C, Pellicer A et al 2006 Obesity and assisted reproductive technology outcomes. Reprod Biomed Online 12:562–568.
The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47.
Diamanti-Kandarakis E, Dunaif A 2012 Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33:981–1030.
De Coster S, van Larebeke N 2012 Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J Environ Public Health 2012:713696 [Epub 2012 Sep 6].
Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al 2009 Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 30:293–242.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pasquali, R. Obesità e infertilità maschile e femminile. L’Endocrinologo 14, 100–104 (2013). https://doi.org/10.1007/BF03346063
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346063